nodes	percent_of_prediction	percent_of_DWPC	metapath
Hydroxocobalamin—TCN1—exocrine gland—uterine cancer	0.0155	0.0508	CbGeAlD
Hydroxocobalamin—Cyanocobalamin—MTHFR—uterine cancer	0.012	1	CrCbGaD
Hydroxocobalamin—CUBN—myometrium—uterine cancer	0.00954	0.0313	CbGeAlD
Hydroxocobalamin—AMN—uterine cervix—uterine cancer	0.00882	0.0289	CbGeAlD
Hydroxocobalamin—AMN—renal system—uterine cancer	0.00826	0.0271	CbGeAlD
Hydroxocobalamin—TCN2—myometrium—uterine cancer	0.00772	0.0253	CbGeAlD
Hydroxocobalamin—CUBN—epithelium—uterine cancer	0.00749	0.0246	CbGeAlD
Hydroxocobalamin—CUBN—renal system—uterine cancer	0.00695	0.0228	CbGeAlD
Hydroxocobalamin—TCN1—uterine cervix—uterine cancer	0.00669	0.0219	CbGeAlD
Hydroxocobalamin—TCN1—decidua—uterine cancer	0.00637	0.0209	CbGeAlD
Hydroxocobalamin—MUT—myometrium—uterine cancer	0.00607	0.0199	CbGeAlD
Hydroxocobalamin—TCN1—endometrium—uterine cancer	0.00605	0.0198	CbGeAlD
Hydroxocobalamin—CASP9—decidua—uterine cancer	0.00586	0.0192	CbGeAlD
Hydroxocobalamin—TCN1—mammalian vulva—uterine cancer	0.00585	0.0192	CbGeAlD
Hydroxocobalamin—CASP9—renal system—uterine cancer	0.00576	0.0189	CbGeAlD
Hydroxocobalamin—TCN2—decidua—uterine cancer	0.00572	0.0188	CbGeAlD
Hydroxocobalamin—TCN2—renal system—uterine cancer	0.00562	0.0184	CbGeAlD
Hydroxocobalamin—CUBN—female reproductive system—uterine cancer	0.00556	0.0182	CbGeAlD
Hydroxocobalamin—MTRR—myometrium—uterine cancer	0.00545	0.0179	CbGeAlD
Hydroxocobalamin—CUBN—female gonad—uterine cancer	0.00506	0.0166	CbGeAlD
Hydroxocobalamin—MMAB—female reproductive system—uterine cancer	0.00494	0.0162	CbGeAlD
Hydroxocobalamin—MMAA—female gonad—uterine cancer	0.00479	0.0157	CbGeAlD
Hydroxocobalamin—MMAA—vagina—uterine cancer	0.00476	0.0156	CbGeAlD
Hydroxocobalamin—MTR—myometrium—uterine cancer	0.00476	0.0156	CbGeAlD
Hydroxocobalamin—MUT—uterine cervix—uterine cancer	0.00472	0.0155	CbGeAlD
Hydroxocobalamin—CASP9—female reproductive system—uterine cancer	0.00461	0.0151	CbGeAlD
Hydroxocobalamin—TCN1—vagina—uterine cancer	0.00453	0.0149	CbGeAlD
Hydroxocobalamin—TCN2—female reproductive system—uterine cancer	0.0045	0.0148	CbGeAlD
Hydroxocobalamin—MUT—decidua—uterine cancer	0.0045	0.0148	CbGeAlD
Hydroxocobalamin—MMAB—female gonad—uterine cancer	0.00449	0.0147	CbGeAlD
Hydroxocobalamin—MMAB—vagina—uterine cancer	0.00446	0.0146	CbGeAlD
Hydroxocobalamin—MUT—renal system—uterine cancer	0.00442	0.0145	CbGeAlD
Hydroxocobalamin—MUT—endometrium—uterine cancer	0.00427	0.014	CbGeAlD
Hydroxocobalamin—MTRR—uterine cervix—uterine cancer	0.00424	0.0139	CbGeAlD
Hydroxocobalamin—CASP9—female gonad—uterine cancer	0.0042	0.0138	CbGeAlD
Hydroxocobalamin—CASP9—vagina—uterine cancer	0.00417	0.0137	CbGeAlD
Hydroxocobalamin—MUT—mammalian vulva—uterine cancer	0.00413	0.0135	CbGeAlD
Hydroxocobalamin—MTRR—decidua—uterine cancer	0.00404	0.0133	CbGeAlD
Hydroxocobalamin—MTRR—renal system—uterine cancer	0.00397	0.013	CbGeAlD
Hydroxocobalamin—MUT—uterus—uterine cancer	0.00394	0.0129	CbGeAlD
Hydroxocobalamin—AMN—lymph node—uterine cancer	0.00387	0.0127	CbGeAlD
Hydroxocobalamin—MTRR—endometrium—uterine cancer	0.00384	0.0126	CbGeAlD
Hydroxocobalamin—MTRR—mammalian vulva—uterine cancer	0.00371	0.0122	CbGeAlD
Hydroxocobalamin—MTR—uterine cervix—uterine cancer	0.0037	0.0121	CbGeAlD
Hydroxocobalamin—MUT—female reproductive system—uterine cancer	0.00354	0.0116	CbGeAlD
Hydroxocobalamin—MTRR—uterus—uterine cancer	0.00354	0.0116	CbGeAlD
Hydroxocobalamin—MTR—decidua—uterine cancer	0.00353	0.0116	CbGeAlD
Hydroxocobalamin—MTR—renal system—uterine cancer	0.00346	0.0114	CbGeAlD
Hydroxocobalamin—MTR—endometrium—uterine cancer	0.00335	0.011	CbGeAlD
Hydroxocobalamin—CUBN—lymph node—uterine cancer	0.00326	0.0107	CbGeAlD
Hydroxocobalamin—MTR—mammalian vulva—uterine cancer	0.00324	0.0106	CbGeAlD
Hydroxocobalamin—MUT—female gonad—uterine cancer	0.00322	0.0106	CbGeAlD
Hydroxocobalamin—MUT—vagina—uterine cancer	0.0032	0.0105	CbGeAlD
Hydroxocobalamin—MTRR—female reproductive system—uterine cancer	0.00318	0.0104	CbGeAlD
Hydroxocobalamin—MTR—uterus—uterine cancer	0.00309	0.0101	CbGeAlD
Hydroxocobalamin—MMAA—lymph node—uterine cancer	0.00308	0.0101	CbGeAlD
Hydroxocobalamin—MTRR—female gonad—uterine cancer	0.00289	0.00949	CbGeAlD
Hydroxocobalamin—MMAB—lymph node—uterine cancer	0.00289	0.00946	CbGeAlD
Hydroxocobalamin—MTRR—vagina—uterine cancer	0.00288	0.00943	CbGeAlD
Hydroxocobalamin—MTR—female reproductive system—uterine cancer	0.00277	0.00909	CbGeAlD
Hydroxocobalamin—CASP9—lymph node—uterine cancer	0.0027	0.00884	CbGeAlD
Hydroxocobalamin—TCN2—lymph node—uterine cancer	0.00263	0.00863	CbGeAlD
Hydroxocobalamin—MTR—female gonad—uterine cancer	0.00252	0.00827	CbGeAlD
Hydroxocobalamin—MTR—vagina—uterine cancer	0.00251	0.00822	CbGeAlD
Hydroxocobalamin—MUT—lymph node—uterine cancer	0.00207	0.00679	CbGeAlD
Hydroxocobalamin—Chest discomfort—Etoposide—uterine cancer	0.00201	0.00592	CcSEcCtD
Hydroxocobalamin—Dysphagia—Medroxyprogesterone Acetate—uterine cancer	0.00198	0.00582	CcSEcCtD
Hydroxocobalamin—Abdominal discomfort—Medroxyprogesterone Acetate—uterine cancer	0.0019	0.00558	CcSEcCtD
Hydroxocobalamin—Body temperature increased—Carboplatin—uterine cancer	0.00187	0.0055	CcSEcCtD
Hydroxocobalamin—MTRR—lymph node—uterine cancer	0.00186	0.0061	CbGeAlD
Hydroxocobalamin—Venous thrombosis—Epirubicin—uterine cancer	0.00185	0.00544	CcSEcCtD
Hydroxocobalamin—Urinary tract disorder—Progesterone—uterine cancer	0.00172	0.00508	CcSEcCtD
Hydroxocobalamin—Oedema peripheral—Progesterone—uterine cancer	0.00172	0.00506	CcSEcCtD
Hydroxocobalamin—Urethral disorder—Progesterone—uterine cancer	0.00171	0.00504	CcSEcCtD
Hydroxocobalamin—Venous thrombosis—Doxorubicin—uterine cancer	0.00171	0.00503	CcSEcCtD
Hydroxocobalamin—Eye disorder—Progesterone—uterine cancer	0.00163	0.0048	CcSEcCtD
Hydroxocobalamin—MTR—lymph node—uterine cancer	0.00162	0.00532	CbGeAlD
Hydroxocobalamin—Cardiac disorder—Progesterone—uterine cancer	0.00162	0.00477	CcSEcCtD
Hydroxocobalamin—Folliculitis—Epirubicin—uterine cancer	0.00159	0.00467	CcSEcCtD
Hydroxocobalamin—Angiopathy—Progesterone—uterine cancer	0.00158	0.00466	CcSEcCtD
Hydroxocobalamin—Immune system disorder—Progesterone—uterine cancer	0.00158	0.00464	CcSEcCtD
Hydroxocobalamin—Mediastinal disorder—Progesterone—uterine cancer	0.00157	0.00463	CcSEcCtD
Hydroxocobalamin—Urinary tract disorder—Medroxyprogesterone Acetate—uterine cancer	0.00156	0.0046	CcSEcCtD
Hydroxocobalamin—Oedema peripheral—Medroxyprogesterone Acetate—uterine cancer	0.00156	0.00459	CcSEcCtD
Hydroxocobalamin—Urethral disorder—Medroxyprogesterone Acetate—uterine cancer	0.00155	0.00457	CcSEcCtD
Hydroxocobalamin—Dysphagia—Dactinomycin—uterine cancer	0.00154	0.00454	CcSEcCtD
Hydroxocobalamin—Mental disorder—Progesterone—uterine cancer	0.00153	0.0045	CcSEcCtD
Hydroxocobalamin—Erythema—Progesterone—uterine cancer	0.00152	0.00447	CcSEcCtD
Hydroxocobalamin—Phlebitis—Etoposide—uterine cancer	0.0015	0.00441	CcSEcCtD
Hydroxocobalamin—Eye disorder—Medroxyprogesterone Acetate—uterine cancer	0.00148	0.00435	CcSEcCtD
Hydroxocobalamin—Redness—Epirubicin—uterine cancer	0.00148	0.00435	CcSEcCtD
Hydroxocobalamin—Cardiac disorder—Medroxyprogesterone Acetate—uterine cancer	0.00147	0.00432	CcSEcCtD
Hydroxocobalamin—Folliculitis—Doxorubicin—uterine cancer	0.00147	0.00432	CcSEcCtD
Hydroxocobalamin—Swelling—Etoposide—uterine cancer	0.00146	0.00431	CcSEcCtD
Hydroxocobalamin—Angiopathy—Medroxyprogesterone Acetate—uterine cancer	0.00144	0.00423	CcSEcCtD
Hydroxocobalamin—Immune system disorder—Medroxyprogesterone Acetate—uterine cancer	0.00143	0.00421	CcSEcCtD
Hydroxocobalamin—Mediastinal disorder—Medroxyprogesterone Acetate—uterine cancer	0.00143	0.0042	CcSEcCtD
Hydroxocobalamin—Cardiac failure congestive—Etoposide—uterine cancer	0.00142	0.00419	CcSEcCtD
Hydroxocobalamin—Chills—Medroxyprogesterone Acetate—uterine cancer	0.00142	0.00418	CcSEcCtD
Hydroxocobalamin—Ill-defined disorder—Progesterone—uterine cancer	0.00141	0.00415	CcSEcCtD
Hydroxocobalamin—Thrombosis—Epirubicin—uterine cancer	0.00141	0.00415	CcSEcCtD
Hydroxocobalamin—Lung disorder—Epirubicin—uterine cancer	0.00141	0.00415	CcSEcCtD
Hydroxocobalamin—Angioedema—Progesterone—uterine cancer	0.00139	0.00409	CcSEcCtD
Hydroxocobalamin—Mental disorder—Medroxyprogesterone Acetate—uterine cancer	0.00139	0.00408	CcSEcCtD
Hydroxocobalamin—Erythema—Medroxyprogesterone Acetate—uterine cancer	0.00138	0.00405	CcSEcCtD
Hydroxocobalamin—Malaise—Progesterone—uterine cancer	0.00137	0.00404	CcSEcCtD
Hydroxocobalamin—Redness—Doxorubicin—uterine cancer	0.00137	0.00402	CcSEcCtD
Hydroxocobalamin—Lung disorder—Doxorubicin—uterine cancer	0.0013	0.00384	CcSEcCtD
Hydroxocobalamin—Thrombosis—Doxorubicin—uterine cancer	0.0013	0.00384	CcSEcCtD
Hydroxocobalamin—Pleural effusion—Epirubicin—uterine cancer	0.0013	0.00383	CcSEcCtD
Hydroxocobalamin—Chest pain—Progesterone—uterine cancer	0.00129	0.00381	CcSEcCtD
Hydroxocobalamin—Unspecified disorder of skin and subcutaneous tissue—Progesterone—uterine cancer	0.00129	0.00378	CcSEcCtD
Hydroxocobalamin—Discomfort—Progesterone—uterine cancer	0.00128	0.00376	CcSEcCtD
Hydroxocobalamin—Ill-defined disorder—Medroxyprogesterone Acetate—uterine cancer	0.00128	0.00376	CcSEcCtD
Hydroxocobalamin—Feeling hot—Epirubicin—uterine cancer	0.00127	0.00374	CcSEcCtD
Hydroxocobalamin—Agitation—Medroxyprogesterone Acetate—uterine cancer	0.00127	0.00373	CcSEcCtD
Hydroxocobalamin—Angioedema—Medroxyprogesterone Acetate—uterine cancer	0.00126	0.00371	CcSEcCtD
Hydroxocobalamin—Malaise—Medroxyprogesterone Acetate—uterine cancer	0.00124	0.00366	CcSEcCtD
Hydroxocobalamin—Anaphylactic shock—Progesterone—uterine cancer	0.00124	0.00365	CcSEcCtD
Hydroxocobalamin—Oedema—Progesterone—uterine cancer	0.00124	0.00365	CcSEcCtD
Hydroxocobalamin—Infection—Progesterone—uterine cancer	0.00123	0.00363	CcSEcCtD
Hydroxocobalamin—Cardiac arrest—Etoposide—uterine cancer	0.00123	0.00361	CcSEcCtD
Hydroxocobalamin—Nervous system disorder—Progesterone—uterine cancer	0.00122	0.00358	CcSEcCtD
Hydroxocobalamin—Tachycardia—Progesterone—uterine cancer	0.00121	0.00356	CcSEcCtD
Hydroxocobalamin—Skin disorder—Progesterone—uterine cancer	0.00121	0.00355	CcSEcCtD
Hydroxocobalamin—Pleural effusion—Doxorubicin—uterine cancer	0.0012	0.00355	CcSEcCtD
Hydroxocobalamin—Feeling hot—Doxorubicin—uterine cancer	0.00118	0.00346	CcSEcCtD
Hydroxocobalamin—Chest pain—Medroxyprogesterone Acetate—uterine cancer	0.00117	0.00345	CcSEcCtD
Hydroxocobalamin—Unspecified disorder of skin and subcutaneous tissue—Medroxyprogesterone Acetate—uterine cancer	0.00116	0.00343	CcSEcCtD
Hydroxocobalamin—Discomfort—Medroxyprogesterone Acetate—uterine cancer	0.00116	0.00341	CcSEcCtD
Hydroxocobalamin—Extravasation—Epirubicin—uterine cancer	0.00114	0.00336	CcSEcCtD
Hydroxocobalamin—Anaphylactic shock—Medroxyprogesterone Acetate—uterine cancer	0.00112	0.00331	CcSEcCtD
Hydroxocobalamin—Oedema—Medroxyprogesterone Acetate—uterine cancer	0.00112	0.00331	CcSEcCtD
Hydroxocobalamin—Infection—Medroxyprogesterone Acetate—uterine cancer	0.00112	0.00329	CcSEcCtD
Hydroxocobalamin—Dysphagia—Etoposide—uterine cancer	0.00112	0.00329	CcSEcCtD
Hydroxocobalamin—Chills—Dactinomycin—uterine cancer	0.00111	0.00326	CcSEcCtD
Hydroxocobalamin—Dyspnoea—Progesterone—uterine cancer	0.00111	0.00326	CcSEcCtD
Hydroxocobalamin—Ventricular extrasystoles—Epirubicin—uterine cancer	0.0011	0.00325	CcSEcCtD
Hydroxocobalamin—Nervous system disorder—Medroxyprogesterone Acetate—uterine cancer	0.0011	0.00325	CcSEcCtD
Hydroxocobalamin—Tachycardia—Medroxyprogesterone Acetate—uterine cancer	0.0011	0.00323	CcSEcCtD
Hydroxocobalamin—Dyspepsia—Progesterone—uterine cancer	0.00109	0.00321	CcSEcCtD
Hydroxocobalamin—Skin disorder—Medroxyprogesterone Acetate—uterine cancer	0.00109	0.00321	CcSEcCtD
Hydroxocobalamin—Erythema—Dactinomycin—uterine cancer	0.00107	0.00316	CcSEcCtD
Hydroxocobalamin—Gastrointestinal disorder—Progesterone—uterine cancer	0.00107	0.00315	CcSEcCtD
Hydroxocobalamin—Pain—Progesterone—uterine cancer	0.00106	0.00312	CcSEcCtD
Hydroxocobalamin—Extravasation—Doxorubicin—uterine cancer	0.00106	0.00311	CcSEcCtD
Hydroxocobalamin—Feeling abnormal—Progesterone—uterine cancer	0.00102	0.00301	CcSEcCtD
Hydroxocobalamin—Ventricular extrasystoles—Doxorubicin—uterine cancer	0.00102	0.00301	CcSEcCtD
Hydroxocobalamin—Dyspnoea—Medroxyprogesterone Acetate—uterine cancer	0.001	0.00295	CcSEcCtD
Hydroxocobalamin—Ill-defined disorder—Dactinomycin—uterine cancer	0.000997	0.00293	CcSEcCtD
Hydroxocobalamin—Injection site reaction—Epirubicin—uterine cancer	0.000991	0.00292	CcSEcCtD
Hydroxocobalamin—Dyspepsia—Medroxyprogesterone Acetate—uterine cancer	0.00099	0.00291	CcSEcCtD
Hydroxocobalamin—Urticaria—Progesterone—uterine cancer	0.000986	0.0029	CcSEcCtD
Hydroxocobalamin—Body temperature increased—Progesterone—uterine cancer	0.000981	0.00289	CcSEcCtD
Hydroxocobalamin—Gastrointestinal disorder—Medroxyprogesterone Acetate—uterine cancer	0.000971	0.00286	CcSEcCtD
Hydroxocobalamin—Malaise—Dactinomycin—uterine cancer	0.000969	0.00285	CcSEcCtD
Hydroxocobalamin—Feeling abnormal—Medroxyprogesterone Acetate—uterine cancer	0.000926	0.00273	CcSEcCtD
Hydroxocobalamin—Injection site reaction—Doxorubicin—uterine cancer	0.000917	0.0027	CcSEcCtD
Hydroxocobalamin—Hypersensitivity—Progesterone—uterine cancer	0.000914	0.00269	CcSEcCtD
Hydroxocobalamin—Discomfort—Dactinomycin—uterine cancer	0.000904	0.00266	CcSEcCtD
Hydroxocobalamin—Urticaria—Medroxyprogesterone Acetate—uterine cancer	0.000893	0.00263	CcSEcCtD
Hydroxocobalamin—Body temperature increased—Medroxyprogesterone Acetate—uterine cancer	0.000889	0.00262	CcSEcCtD
Hydroxocobalamin—Pulmonary oedema—Epirubicin—uterine cancer	0.000888	0.00261	CcSEcCtD
Hydroxocobalamin—Urinary tract disorder—Etoposide—uterine cancer	0.000882	0.0026	CcSEcCtD
Hydroxocobalamin—Pruritus—Progesterone—uterine cancer	0.000878	0.00258	CcSEcCtD
Hydroxocobalamin—Oedema—Dactinomycin—uterine cancer	0.000877	0.00258	CcSEcCtD
Hydroxocobalamin—Urethral disorder—Etoposide—uterine cancer	0.000876	0.00258	CcSEcCtD
Hydroxocobalamin—Infection—Dactinomycin—uterine cancer	0.000871	0.00256	CcSEcCtD
Hydroxocobalamin—Diarrhoea—Progesterone—uterine cancer	0.000849	0.0025	CcSEcCtD
Hydroxocobalamin—Phlebitis—Epirubicin—uterine cancer	0.00084	0.00247	CcSEcCtD
Hydroxocobalamin—Eye disorder—Etoposide—uterine cancer	0.000835	0.00246	CcSEcCtD
Hydroxocobalamin—Cardiac disorder—Etoposide—uterine cancer	0.000829	0.00244	CcSEcCtD
Hydroxocobalamin—Hypersensitivity—Medroxyprogesterone Acetate—uterine cancer	0.000828	0.00244	CcSEcCtD
Hydroxocobalamin—Pulmonary oedema—Doxorubicin—uterine cancer	0.000821	0.00242	CcSEcCtD
Hydroxocobalamin—Dizziness—Progesterone—uterine cancer	0.00082	0.00241	CcSEcCtD
Hydroxocobalamin—Angiopathy—Etoposide—uterine cancer	0.00081	0.00239	CcSEcCtD
Hydroxocobalamin—Immune system disorder—Etoposide—uterine cancer	0.000807	0.00238	CcSEcCtD
Hydroxocobalamin—Eczema—Epirubicin—uterine cancer	0.000805	0.00237	CcSEcCtD
Hydroxocobalamin—Mediastinal disorder—Etoposide—uterine cancer	0.000805	0.00237	CcSEcCtD
Hydroxocobalamin—Chills—Etoposide—uterine cancer	0.000802	0.00236	CcSEcCtD
Hydroxocobalamin—Cardiac failure congestive—Epirubicin—uterine cancer	0.000798	0.00235	CcSEcCtD
Hydroxocobalamin—Pruritus—Medroxyprogesterone Acetate—uterine cancer	0.000795	0.00234	CcSEcCtD
Hydroxocobalamin—Rash—Progesterone—uterine cancer	0.000782	0.0023	CcSEcCtD
Hydroxocobalamin—Dermatitis—Progesterone—uterine cancer	0.000782	0.0023	CcSEcCtD
Hydroxocobalamin—Phlebitis—Doxorubicin—uterine cancer	0.000777	0.00229	CcSEcCtD
Hydroxocobalamin—Headache—Progesterone—uterine cancer	0.000777	0.00229	CcSEcCtD
Hydroxocobalamin—Hot flush—Epirubicin—uterine cancer	0.000774	0.00228	CcSEcCtD
Hydroxocobalamin—Diarrhoea—Medroxyprogesterone Acetate—uterine cancer	0.000769	0.00226	CcSEcCtD
Hydroxocobalamin—Menopausal symptoms—Epirubicin—uterine cancer	0.000767	0.00226	CcSEcCtD
Hydroxocobalamin—Dermatitis bullous—Epirubicin—uterine cancer	0.000757	0.00223	CcSEcCtD
Hydroxocobalamin—Pain—Dactinomycin—uterine cancer	0.00075	0.00221	CcSEcCtD
Hydroxocobalamin—Eczema—Doxorubicin—uterine cancer	0.000745	0.00219	CcSEcCtD
Hydroxocobalamin—Dizziness—Medroxyprogesterone Acetate—uterine cancer	0.000743	0.00219	CcSEcCtD
Hydroxocobalamin—Cardiac failure congestive—Doxorubicin—uterine cancer	0.000739	0.00217	CcSEcCtD
Hydroxocobalamin—Nausea—Progesterone—uterine cancer	0.000737	0.00217	CcSEcCtD
Hydroxocobalamin—Hyponatraemia—Epirubicin—uterine cancer	0.000727	0.00214	CcSEcCtD
Hydroxocobalamin—Feeling abnormal—Dactinomycin—uterine cancer	0.000723	0.00213	CcSEcCtD
Hydroxocobalamin—Ill-defined disorder—Etoposide—uterine cancer	0.000722	0.00212	CcSEcCtD
Hydroxocobalamin—Hot flush—Doxorubicin—uterine cancer	0.000716	0.00211	CcSEcCtD
Hydroxocobalamin—Menopausal symptoms—Doxorubicin—uterine cancer	0.00071	0.00209	CcSEcCtD
Hydroxocobalamin—Rash—Medroxyprogesterone Acetate—uterine cancer	0.000709	0.00209	CcSEcCtD
Hydroxocobalamin—Dermatitis—Medroxyprogesterone Acetate—uterine cancer	0.000708	0.00208	CcSEcCtD
Hydroxocobalamin—Headache—Medroxyprogesterone Acetate—uterine cancer	0.000704	0.00207	CcSEcCtD
Hydroxocobalamin—Malaise—Etoposide—uterine cancer	0.000701	0.00206	CcSEcCtD
Hydroxocobalamin—Dermatitis bullous—Doxorubicin—uterine cancer	0.000701	0.00206	CcSEcCtD
Hydroxocobalamin—Body temperature increased—Dactinomycin—uterine cancer	0.000693	0.00204	CcSEcCtD
Hydroxocobalamin—Cardiac arrest—Epirubicin—uterine cancer	0.000688	0.00203	CcSEcCtD
Hydroxocobalamin—Hyponatraemia—Doxorubicin—uterine cancer	0.000672	0.00198	CcSEcCtD
Hydroxocobalamin—Nausea—Medroxyprogesterone Acetate—uterine cancer	0.000668	0.00197	CcSEcCtD
Hydroxocobalamin—Chest pain—Etoposide—uterine cancer	0.000662	0.00195	CcSEcCtD
Hydroxocobalamin—Hypokalaemia—Epirubicin—uterine cancer	0.000659	0.00194	CcSEcCtD
Hydroxocobalamin—Unspecified disorder of skin and subcutaneous tissue—Etoposide—uterine cancer	0.000657	0.00194	CcSEcCtD
Hydroxocobalamin—Discomfort—Etoposide—uterine cancer	0.000654	0.00193	CcSEcCtD
Hydroxocobalamin—Hypersensitivity—Dactinomycin—uterine cancer	0.000646	0.0019	CcSEcCtD
Hydroxocobalamin—Cardiac arrest—Doxorubicin—uterine cancer	0.000637	0.00187	CcSEcCtD
Hydroxocobalamin—Anaphylactic shock—Etoposide—uterine cancer	0.000635	0.00187	CcSEcCtD
Hydroxocobalamin—Infection—Etoposide—uterine cancer	0.000631	0.00186	CcSEcCtD
Hydroxocobalamin—Dysphagia—Epirubicin—uterine cancer	0.000626	0.00184	CcSEcCtD
Hydroxocobalamin—Tachycardia—Etoposide—uterine cancer	0.000619	0.00182	CcSEcCtD
Hydroxocobalamin—Skin disorder—Etoposide—uterine cancer	0.000616	0.00181	CcSEcCtD
Hydroxocobalamin—Hypokalaemia—Doxorubicin—uterine cancer	0.00061	0.00179	CcSEcCtD
Hydroxocobalamin—Diarrhoea—Dactinomycin—uterine cancer	0.0006	0.00177	CcSEcCtD
Hydroxocobalamin—Dysphagia—Doxorubicin—uterine cancer	0.000579	0.0017	CcSEcCtD
Hydroxocobalamin—Dyspnoea—Etoposide—uterine cancer	0.000566	0.00167	CcSEcCtD
Hydroxocobalamin—Rash—Dactinomycin—uterine cancer	0.000553	0.00163	CcSEcCtD
Hydroxocobalamin—Gastrointestinal disorder—Etoposide—uterine cancer	0.000548	0.00161	CcSEcCtD
Hydroxocobalamin—Pain—Etoposide—uterine cancer	0.000543	0.0016	CcSEcCtD
Hydroxocobalamin—Feeling abnormal—Etoposide—uterine cancer	0.000523	0.00154	CcSEcCtD
Hydroxocobalamin—Nausea—Dactinomycin—uterine cancer	0.000521	0.00153	CcSEcCtD
Hydroxocobalamin—Urticaria—Etoposide—uterine cancer	0.000504	0.00148	CcSEcCtD
Hydroxocobalamin—Body temperature increased—Etoposide—uterine cancer	0.000502	0.00148	CcSEcCtD
Hydroxocobalamin—Urinary tract disorder—Epirubicin—uterine cancer	0.000495	0.00146	CcSEcCtD
Hydroxocobalamin—Oedema peripheral—Epirubicin—uterine cancer	0.000493	0.00145	CcSEcCtD
Hydroxocobalamin—Urethral disorder—Epirubicin—uterine cancer	0.000491	0.00144	CcSEcCtD
Hydroxocobalamin—Eye disorder—Epirubicin—uterine cancer	0.000468	0.00138	CcSEcCtD
Hydroxocobalamin—Hypersensitivity—Etoposide—uterine cancer	0.000468	0.00138	CcSEcCtD
Hydroxocobalamin—Cardiac disorder—Epirubicin—uterine cancer	0.000465	0.00137	CcSEcCtD
Hydroxocobalamin—Urinary tract disorder—Doxorubicin—uterine cancer	0.000458	0.00135	CcSEcCtD
Hydroxocobalamin—Oedema peripheral—Doxorubicin—uterine cancer	0.000456	0.00134	CcSEcCtD
Hydroxocobalamin—Angiopathy—Epirubicin—uterine cancer	0.000454	0.00134	CcSEcCtD
Hydroxocobalamin—Urethral disorder—Doxorubicin—uterine cancer	0.000454	0.00134	CcSEcCtD
Hydroxocobalamin—Immune system disorder—Epirubicin—uterine cancer	0.000452	0.00133	CcSEcCtD
Hydroxocobalamin—Mediastinal disorder—Epirubicin—uterine cancer	0.000451	0.00133	CcSEcCtD
Hydroxocobalamin—Chills—Epirubicin—uterine cancer	0.000449	0.00132	CcSEcCtD
Hydroxocobalamin—Pruritus—Etoposide—uterine cancer	0.000449	0.00132	CcSEcCtD
Hydroxocobalamin—Arrhythmia—Epirubicin—uterine cancer	0.000447	0.00132	CcSEcCtD
Hydroxocobalamin—Mental disorder—Epirubicin—uterine cancer	0.000439	0.00129	CcSEcCtD
Hydroxocobalamin—Erythema—Epirubicin—uterine cancer	0.000436	0.00128	CcSEcCtD
Hydroxocobalamin—Diarrhoea—Etoposide—uterine cancer	0.000434	0.00128	CcSEcCtD
Hydroxocobalamin—Eye disorder—Doxorubicin—uterine cancer	0.000433	0.00127	CcSEcCtD
Hydroxocobalamin—Cardiac disorder—Doxorubicin—uterine cancer	0.00043	0.00127	CcSEcCtD
Hydroxocobalamin—Angiopathy—Doxorubicin—uterine cancer	0.00042	0.00124	CcSEcCtD
Hydroxocobalamin—Dizziness—Etoposide—uterine cancer	0.00042	0.00124	CcSEcCtD
Hydroxocobalamin—Immune system disorder—Doxorubicin—uterine cancer	0.000418	0.00123	CcSEcCtD
Hydroxocobalamin—Mediastinal disorder—Doxorubicin—uterine cancer	0.000418	0.00123	CcSEcCtD
Hydroxocobalamin—Chills—Doxorubicin—uterine cancer	0.000416	0.00122	CcSEcCtD
Hydroxocobalamin—Arrhythmia—Doxorubicin—uterine cancer	0.000414	0.00122	CcSEcCtD
Hydroxocobalamin—Mental disorder—Doxorubicin—uterine cancer	0.000406	0.00119	CcSEcCtD
Hydroxocobalamin—Ill-defined disorder—Epirubicin—uterine cancer	0.000404	0.00119	CcSEcCtD
Hydroxocobalamin—Erythema—Doxorubicin—uterine cancer	0.000403	0.00119	CcSEcCtD
Hydroxocobalamin—Agitation—Epirubicin—uterine cancer	0.000401	0.00118	CcSEcCtD
Hydroxocobalamin—Rash—Etoposide—uterine cancer	0.0004	0.00118	CcSEcCtD
Hydroxocobalamin—Dermatitis—Etoposide—uterine cancer	0.0004	0.00118	CcSEcCtD
Hydroxocobalamin—Headache—Etoposide—uterine cancer	0.000398	0.00117	CcSEcCtD
Hydroxocobalamin—Malaise—Epirubicin—uterine cancer	0.000393	0.00116	CcSEcCtD
Hydroxocobalamin—Nausea—Etoposide—uterine cancer	0.000377	0.00111	CcSEcCtD
Hydroxocobalamin—Ill-defined disorder—Doxorubicin—uterine cancer	0.000374	0.0011	CcSEcCtD
Hydroxocobalamin—Chest pain—Epirubicin—uterine cancer	0.000371	0.00109	CcSEcCtD
Hydroxocobalamin—Agitation—Doxorubicin—uterine cancer	0.000371	0.00109	CcSEcCtD
Hydroxocobalamin—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—uterine cancer	0.000369	0.00108	CcSEcCtD
Hydroxocobalamin—Discomfort—Epirubicin—uterine cancer	0.000367	0.00108	CcSEcCtD
Hydroxocobalamin—Malaise—Doxorubicin—uterine cancer	0.000364	0.00107	CcSEcCtD
Hydroxocobalamin—Oedema—Epirubicin—uterine cancer	0.000356	0.00105	CcSEcCtD
Hydroxocobalamin—Anaphylactic shock—Epirubicin—uterine cancer	0.000356	0.00105	CcSEcCtD
Hydroxocobalamin—Infection—Epirubicin—uterine cancer	0.000353	0.00104	CcSEcCtD
Hydroxocobalamin—Nervous system disorder—Epirubicin—uterine cancer	0.000349	0.00103	CcSEcCtD
Hydroxocobalamin—Tachycardia—Epirubicin—uterine cancer	0.000347	0.00102	CcSEcCtD
Hydroxocobalamin—Skin disorder—Epirubicin—uterine cancer	0.000346	0.00102	CcSEcCtD
Hydroxocobalamin—Chest pain—Doxorubicin—uterine cancer	0.000343	0.00101	CcSEcCtD
Hydroxocobalamin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—uterine cancer	0.000341	0.001	CcSEcCtD
Hydroxocobalamin—Discomfort—Doxorubicin—uterine cancer	0.000339	0.000999	CcSEcCtD
Hydroxocobalamin—Oedema—Doxorubicin—uterine cancer	0.000329	0.000969	CcSEcCtD
Hydroxocobalamin—Anaphylactic shock—Doxorubicin—uterine cancer	0.000329	0.000969	CcSEcCtD
Hydroxocobalamin—Infection—Doxorubicin—uterine cancer	0.000327	0.000963	CcSEcCtD
Hydroxocobalamin—Nervous system disorder—Doxorubicin—uterine cancer	0.000323	0.00095	CcSEcCtD
Hydroxocobalamin—Tachycardia—Doxorubicin—uterine cancer	0.000321	0.000946	CcSEcCtD
Hydroxocobalamin—Skin disorder—Doxorubicin—uterine cancer	0.00032	0.000941	CcSEcCtD
Hydroxocobalamin—Dyspnoea—Epirubicin—uterine cancer	0.000317	0.000934	CcSEcCtD
Hydroxocobalamin—Dyspepsia—Epirubicin—uterine cancer	0.000313	0.000922	CcSEcCtD
Hydroxocobalamin—Gastrointestinal disorder—Epirubicin—uterine cancer	0.000307	0.000904	CcSEcCtD
Hydroxocobalamin—Pain—Epirubicin—uterine cancer	0.000304	0.000896	CcSEcCtD
Hydroxocobalamin—Dyspnoea—Doxorubicin—uterine cancer	0.000293	0.000864	CcSEcCtD
Hydroxocobalamin—Feeling abnormal—Epirubicin—uterine cancer	0.000293	0.000863	CcSEcCtD
Hydroxocobalamin—Dyspepsia—Doxorubicin—uterine cancer	0.00029	0.000853	CcSEcCtD
Hydroxocobalamin—Gastrointestinal disorder—Doxorubicin—uterine cancer	0.000284	0.000837	CcSEcCtD
Hydroxocobalamin—Urticaria—Epirubicin—uterine cancer	0.000283	0.000832	CcSEcCtD
Hydroxocobalamin—Pain—Doxorubicin—uterine cancer	0.000281	0.000829	CcSEcCtD
Hydroxocobalamin—Body temperature increased—Epirubicin—uterine cancer	0.000281	0.000828	CcSEcCtD
Hydroxocobalamin—Feeling abnormal—Doxorubicin—uterine cancer	0.000271	0.000798	CcSEcCtD
Hydroxocobalamin—Hypersensitivity—Epirubicin—uterine cancer	0.000262	0.000772	CcSEcCtD
Hydroxocobalamin—Urticaria—Doxorubicin—uterine cancer	0.000261	0.00077	CcSEcCtD
Hydroxocobalamin—Body temperature increased—Doxorubicin—uterine cancer	0.00026	0.000766	CcSEcCtD
Hydroxocobalamin—Pruritus—Epirubicin—uterine cancer	0.000252	0.000741	CcSEcCtD
Hydroxocobalamin—Diarrhoea—Epirubicin—uterine cancer	0.000243	0.000717	CcSEcCtD
Hydroxocobalamin—Hypersensitivity—Doxorubicin—uterine cancer	0.000243	0.000714	CcSEcCtD
Hydroxocobalamin—Dizziness—Epirubicin—uterine cancer	0.000235	0.000692	CcSEcCtD
Hydroxocobalamin—Pruritus—Doxorubicin—uterine cancer	0.000233	0.000686	CcSEcCtD
Hydroxocobalamin—Diarrhoea—Doxorubicin—uterine cancer	0.000225	0.000663	CcSEcCtD
Hydroxocobalamin—Rash—Epirubicin—uterine cancer	0.000224	0.00066	CcSEcCtD
Hydroxocobalamin—Dermatitis—Epirubicin—uterine cancer	0.000224	0.00066	CcSEcCtD
Hydroxocobalamin—Headache—Epirubicin—uterine cancer	0.000223	0.000656	CcSEcCtD
Hydroxocobalamin—Dizziness—Doxorubicin—uterine cancer	0.000218	0.000641	CcSEcCtD
Hydroxocobalamin—Nausea—Epirubicin—uterine cancer	0.000211	0.000622	CcSEcCtD
Hydroxocobalamin—Rash—Doxorubicin—uterine cancer	0.000208	0.000611	CcSEcCtD
Hydroxocobalamin—Dermatitis—Doxorubicin—uterine cancer	0.000207	0.00061	CcSEcCtD
Hydroxocobalamin—Headache—Doxorubicin—uterine cancer	0.000206	0.000607	CcSEcCtD
Hydroxocobalamin—Nausea—Doxorubicin—uterine cancer	0.000196	0.000576	CcSEcCtD
Hydroxocobalamin—CASP9—Signaling by PDGF—HRAS—uterine cancer	0.000136	0.000397	CbGpPWpGaD
Hydroxocobalamin—MMACHC—Disease—CTNNB1—uterine cancer	0.000136	0.000396	CbGpPWpGaD
Hydroxocobalamin—MTRR—Disease—FGFR2—uterine cancer	0.000136	0.000395	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—HMGA1—uterine cancer	0.000133	0.000388	CbGpPWpGaD
Hydroxocobalamin—CASP9—NGF signalling via TRKA from the plasma membrane—PIK3CA—uterine cancer	0.000133	0.000388	CbGpPWpGaD
Hydroxocobalamin—MMAA—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	0.000133	0.000388	CbGpPWpGaD
Hydroxocobalamin—AMN—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	0.000133	0.000388	CbGpPWpGaD
Hydroxocobalamin—CUBN—Metabolism—MTHFR—uterine cancer	0.000133	0.000388	CbGpPWpGaD
Hydroxocobalamin—CASP9—Downstream signal transduction—AKT1—uterine cancer	0.000133	0.000386	CbGpPWpGaD
Hydroxocobalamin—MMACHC—Disease—PTEN—uterine cancer	0.000133	0.000386	CbGpPWpGaD
Hydroxocobalamin—TCN2—Disease—ERBB2—uterine cancer	0.000132	0.000385	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—FBXW7—uterine cancer	0.000132	0.000385	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling by FGFR—AKT1—uterine cancer	0.000132	0.000384	CbGpPWpGaD
Hydroxocobalamin—MMAB—Disease—CDKN1B—uterine cancer	0.000132	0.000383	CbGpPWpGaD
Hydroxocobalamin—TCN1—Disease—CDKN1B—uterine cancer	0.000132	0.000383	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling by ERBB2—AKT1—uterine cancer	0.000131	0.000382	CbGpPWpGaD
Hydroxocobalamin—CASP9—DAP12 signaling—AKT1—uterine cancer	0.000131	0.000381	CbGpPWpGaD
Hydroxocobalamin—MTRR—Disease—MTHFR—uterine cancer	0.000131	0.00038	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling by NGF—NRAS—uterine cancer	0.00013	0.000378	CbGpPWpGaD
Hydroxocobalamin—CASP9—B Cell Activation—HRAS—uterine cancer	0.000129	0.000375	CbGpPWpGaD
Hydroxocobalamin—CASP9—Downstream signaling events of B Cell Receptor (BCR)—AKT1—uterine cancer	0.000129	0.000375	CbGpPWpGaD
Hydroxocobalamin—CASP9—MAPK Signaling Pathway—AKT1—uterine cancer	0.000128	0.000373	CbGpPWpGaD
Hydroxocobalamin—MUT—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	0.000127	0.00037	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—CDKN2B—uterine cancer	0.000127	0.00037	CbGpPWpGaD
Hydroxocobalamin—MMACHC—Disease—EP300—uterine cancer	0.000126	0.000368	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—AKR1C1—uterine cancer	0.000124	0.000363	CbGpPWpGaD
Hydroxocobalamin—MMAB—Disease—CTNNB1—uterine cancer	0.000124	0.000362	CbGpPWpGaD
Hydroxocobalamin—TCN1—Disease—CTNNB1—uterine cancer	0.000124	0.000362	CbGpPWpGaD
Hydroxocobalamin—CASP9—NGF signalling via TRKA from the plasma membrane—HRAS—uterine cancer	0.000123	0.000359	CbGpPWpGaD
Hydroxocobalamin—CASP9—DAP12 interactions—AKT1—uterine cancer	0.000123	0.000358	CbGpPWpGaD
Hydroxocobalamin—CASP9—Fc epsilon receptor (FCERI) signaling—AKT1—uterine cancer	0.000123	0.000358	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling by FGFR in disease—AKT1—uterine cancer	0.000123	0.000358	CbGpPWpGaD
Hydroxocobalamin—TCN2—Disease—CDKN1B—uterine cancer	0.000122	0.000357	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—FBXW7—uterine cancer	0.000122	0.000355	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling by EGFR—AKT1—uterine cancer	0.000122	0.000355	CbGpPWpGaD
Hydroxocobalamin—TCN1—Disease—PTEN—uterine cancer	0.000121	0.000353	CbGpPWpGaD
Hydroxocobalamin—MMAB—Disease—PTEN—uterine cancer	0.000121	0.000353	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling by EGFR in Cancer—AKT1—uterine cancer	0.000121	0.000352	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling by PDGF—AKT1—uterine cancer	0.00012	0.00035	CbGpPWpGaD
Hydroxocobalamin—MTR—Metabolism—CYP19A1—uterine cancer	0.000119	0.000345	CbGpPWpGaD
Hydroxocobalamin—MTR—Metabolism—STK11—uterine cancer	0.000119	0.000345	CbGpPWpGaD
Hydroxocobalamin—MMACHC—Disease—NRAS—uterine cancer	0.000118	0.000344	CbGpPWpGaD
Hydroxocobalamin—AMN—Disease—ERBB2—uterine cancer	0.000118	0.000343	CbGpPWpGaD
Hydroxocobalamin—MMAA—Disease—ERBB2—uterine cancer	0.000118	0.000343	CbGpPWpGaD
Hydroxocobalamin—CUBN—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	0.000117	0.000342	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—SMAD3—uterine cancer	0.000116	0.000338	CbGpPWpGaD
Hydroxocobalamin—CASP9—Integrated Pancreatic Cancer Pathway—AKT1—uterine cancer	0.000116	0.000337	CbGpPWpGaD
Hydroxocobalamin—TCN2—Disease—CTNNB1—uterine cancer	0.000116	0.000337	CbGpPWpGaD
Hydroxocobalamin—TCN1—Disease—EP300—uterine cancer	0.000116	0.000337	CbGpPWpGaD
Hydroxocobalamin—MMAB—Disease—EP300—uterine cancer	0.000116	0.000337	CbGpPWpGaD
Hydroxocobalamin—CASP9—B Cell Activation—AKT1—uterine cancer	0.000114	0.000331	CbGpPWpGaD
Hydroxocobalamin—TCN2—Disease—PTEN—uterine cancer	0.000113	0.000328	CbGpPWpGaD
Hydroxocobalamin—MUT—Disease—ERBB2—uterine cancer	0.000112	0.000327	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling by NGF—KRAS—uterine cancer	0.000112	0.000325	CbGpPWpGaD
Hydroxocobalamin—MMACHC—Metabolism—PTEN—uterine cancer	0.000111	0.000323	CbGpPWpGaD
Hydroxocobalamin—CASP9—Adaptive Immune System—CDH1—uterine cancer	0.000111	0.000322	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—FGFR2—uterine cancer	0.000111	0.000322	CbGpPWpGaD
Hydroxocobalamin—MTRR—Metabolism—MTHFR—uterine cancer	0.000109	0.000318	CbGpPWpGaD
Hydroxocobalamin—AMN—Disease—CDKN1B—uterine cancer	0.000109	0.000318	CbGpPWpGaD
Hydroxocobalamin—MMAA—Disease—CDKN1B—uterine cancer	0.000109	0.000318	CbGpPWpGaD
Hydroxocobalamin—CASP9—NGF signalling via TRKA from the plasma membrane—AKT1—uterine cancer	0.000109	0.000317	CbGpPWpGaD
Hydroxocobalamin—MMAB—Disease—NRAS—uterine cancer	0.000108	0.000315	CbGpPWpGaD
Hydroxocobalamin—TCN1—Disease—NRAS—uterine cancer	0.000108	0.000315	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—SOCS3—uterine cancer	0.000108	0.000315	CbGpPWpGaD
Hydroxocobalamin—TCN2—Disease—EP300—uterine cancer	0.000107	0.000313	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—MTHFR—uterine cancer	0.000106	0.00031	CbGpPWpGaD
Hydroxocobalamin—MMACHC—Metabolism—EP300—uterine cancer	0.000106	0.000308	CbGpPWpGaD
Hydroxocobalamin—MUT—Disease—CDKN1B—uterine cancer	0.000104	0.000303	CbGpPWpGaD
Hydroxocobalamin—CUBN—Disease—ERBB2—uterine cancer	0.000104	0.000302	CbGpPWpGaD
Hydroxocobalamin—AMN—Disease—CTNNB1—uterine cancer	0.000103	0.0003	CbGpPWpGaD
Hydroxocobalamin—MMAA—Disease—CTNNB1—uterine cancer	0.000103	0.0003	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling by NGF—PIK3CA—uterine cancer	0.000102	0.000299	CbGpPWpGaD
Hydroxocobalamin—MMACHC—Disease—KRAS—uterine cancer	0.000102	0.000296	CbGpPWpGaD
Hydroxocobalamin—MMAB—Metabolism—PTEN—uterine cancer	0.000101	0.000296	CbGpPWpGaD
Hydroxocobalamin—TCN1—Metabolism—PTEN—uterine cancer	0.000101	0.000296	CbGpPWpGaD
Hydroxocobalamin—TCN2—Disease—NRAS—uterine cancer	0.000101	0.000293	CbGpPWpGaD
Hydroxocobalamin—AMN—Disease—PTEN—uterine cancer	0.0001	0.000293	CbGpPWpGaD
Hydroxocobalamin—MMAA—Disease—PTEN—uterine cancer	0.0001	0.000293	CbGpPWpGaD
Hydroxocobalamin—MUT—Disease—CTNNB1—uterine cancer	9.83e-05	0.000286	CbGpPWpGaD
Hydroxocobalamin—CASP9—Innate Immune System—ERBB2—uterine cancer	9.72e-05	0.000283	CbGpPWpGaD
Hydroxocobalamin—TCN1—Metabolism—EP300—uterine cancer	9.68e-05	0.000282	CbGpPWpGaD
Hydroxocobalamin—MMAB—Metabolism—EP300—uterine cancer	9.68e-05	0.000282	CbGpPWpGaD
Hydroxocobalamin—CUBN—Disease—CDKN1B—uterine cancer	9.6e-05	0.00028	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—AKR1C3—uterine cancer	9.58e-05	0.000279	CbGpPWpGaD
Hydroxocobalamin—MUT—Disease—PTEN—uterine cancer	9.58e-05	0.000279	CbGpPWpGaD
Hydroxocobalamin—AMN—Disease—EP300—uterine cancer	9.58e-05	0.000279	CbGpPWpGaD
Hydroxocobalamin—MMAA—Disease—EP300—uterine cancer	9.58e-05	0.000279	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—CDKN2B—uterine cancer	9.55e-05	0.000278	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling by NGF—HRAS—uterine cancer	9.48e-05	0.000276	CbGpPWpGaD
Hydroxocobalamin—TCN2—Metabolism—PTEN—uterine cancer	9.44e-05	0.000275	CbGpPWpGaD
Hydroxocobalamin—MMACHC—Disease—PIK3CA—uterine cancer	9.35e-05	0.000272	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—PGR—uterine cancer	9.34e-05	0.000272	CbGpPWpGaD
Hydroxocobalamin—CASP9—Adaptive Immune System—ERBB2—uterine cancer	9.33e-05	0.000272	CbGpPWpGaD
Hydroxocobalamin—TCN1—Disease—KRAS—uterine cancer	9.31e-05	0.000271	CbGpPWpGaD
Hydroxocobalamin—MMAB—Disease—KRAS—uterine cancer	9.31e-05	0.000271	CbGpPWpGaD
Hydroxocobalamin—MUT—Disease—EP300—uterine cancer	9.14e-05	0.000266	CbGpPWpGaD
Hydroxocobalamin—CUBN—Disease—CTNNB1—uterine cancer	9.07e-05	0.000264	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—FGFR2—uterine cancer	9.01e-05	0.000263	CbGpPWpGaD
Hydroxocobalamin—CASP9—Innate Immune System—CDKN1B—uterine cancer	9e-05	0.000262	CbGpPWpGaD
Hydroxocobalamin—TCN2—Metabolism—EP300—uterine cancer	9e-05	0.000262	CbGpPWpGaD
Hydroxocobalamin—MMAA—Disease—NRAS—uterine cancer	8.96e-05	0.000261	CbGpPWpGaD
Hydroxocobalamin—AMN—Disease—NRAS—uterine cancer	8.96e-05	0.000261	CbGpPWpGaD
Hydroxocobalamin—MTR—Metabolism—MTHFR—uterine cancer	8.91e-05	0.00026	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—YWHAE—uterine cancer	8.91e-05	0.00026	CbGpPWpGaD
Hydroxocobalamin—CUBN—Disease—PTEN—uterine cancer	8.84e-05	0.000258	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—SMAD3—uterine cancer	8.72e-05	0.000254	CbGpPWpGaD
Hydroxocobalamin—TCN2—Disease—KRAS—uterine cancer	8.65e-05	0.000252	CbGpPWpGaD
Hydroxocobalamin—MMACHC—Disease—HRAS—uterine cancer	8.65e-05	0.000252	CbGpPWpGaD
Hydroxocobalamin—CASP9—Adaptive Immune System—CDKN1B—uterine cancer	8.64e-05	0.000252	CbGpPWpGaD
Hydroxocobalamin—TCN1—Disease—PIK3CA—uterine cancer	8.55e-05	0.000249	CbGpPWpGaD
Hydroxocobalamin—MMAB—Disease—PIK3CA—uterine cancer	8.55e-05	0.000249	CbGpPWpGaD
Hydroxocobalamin—MUT—Disease—NRAS—uterine cancer	8.55e-05	0.000249	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—FBXW7—uterine cancer	8.54e-05	0.000249	CbGpPWpGaD
Hydroxocobalamin—MTRR—Disease—ERBB2—uterine cancer	8.51e-05	0.000248	CbGpPWpGaD
Hydroxocobalamin—CASP9—Innate Immune System—CTNNB1—uterine cancer	8.5e-05	0.000248	CbGpPWpGaD
Hydroxocobalamin—CUBN—Disease—EP300—uterine cancer	8.43e-05	0.000246	CbGpPWpGaD
Hydroxocobalamin—AMN—Metabolism—PTEN—uterine cancer	8.41e-05	0.000245	CbGpPWpGaD
Hydroxocobalamin—MMAA—Metabolism—PTEN—uterine cancer	8.41e-05	0.000245	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling by NGF—AKT1—uterine cancer	8.37e-05	0.000244	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—FGFR2—uterine cancer	8.32e-05	0.000242	CbGpPWpGaD
Hydroxocobalamin—CASP9—Innate Immune System—PTEN—uterine cancer	8.29e-05	0.000241	CbGpPWpGaD
Hydroxocobalamin—MUT—Metabolism—PTEN—uterine cancer	8.02e-05	0.000234	CbGpPWpGaD
Hydroxocobalamin—AMN—Metabolism—EP300—uterine cancer	8.02e-05	0.000234	CbGpPWpGaD
Hydroxocobalamin—MMAA—Metabolism—EP300—uterine cancer	8.02e-05	0.000234	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—MTHFR—uterine cancer	8.01e-05	0.000233	CbGpPWpGaD
Hydroxocobalamin—CASP9—Adaptive Immune System—PTEN—uterine cancer	7.96e-05	0.000232	CbGpPWpGaD
Hydroxocobalamin—TCN2—Disease—PIK3CA—uterine cancer	7.95e-05	0.000232	CbGpPWpGaD
Hydroxocobalamin—MMAB—Disease—HRAS—uterine cancer	7.91e-05	0.00023	CbGpPWpGaD
Hydroxocobalamin—TCN1—Disease—HRAS—uterine cancer	7.91e-05	0.00023	CbGpPWpGaD
Hydroxocobalamin—CASP9—Innate Immune System—EP300—uterine cancer	7.9e-05	0.00023	CbGpPWpGaD
Hydroxocobalamin—CUBN—Disease—NRAS—uterine cancer	7.89e-05	0.00023	CbGpPWpGaD
Hydroxocobalamin—MTRR—Disease—CDKN1B—uterine cancer	7.88e-05	0.00023	CbGpPWpGaD
Hydroxocobalamin—MMACHC—Metabolism—PIK3CA—uterine cancer	7.83e-05	0.000228	CbGpPWpGaD
Hydroxocobalamin—MMAA—Disease—KRAS—uterine cancer	7.71e-05	0.000225	CbGpPWpGaD
Hydroxocobalamin—AMN—Disease—KRAS—uterine cancer	7.71e-05	0.000225	CbGpPWpGaD
Hydroxocobalamin—MUT—Metabolism—EP300—uterine cancer	7.65e-05	0.000223	CbGpPWpGaD
Hydroxocobalamin—MMACHC—Disease—AKT1—uterine cancer	7.64e-05	0.000222	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—STK11—uterine cancer	7.46e-05	0.000217	CbGpPWpGaD
Hydroxocobalamin—MTRR—Disease—CTNNB1—uterine cancer	7.45e-05	0.000217	CbGpPWpGaD
Hydroxocobalamin—CUBN—Metabolism—PTEN—uterine cancer	7.4e-05	0.000216	CbGpPWpGaD
Hydroxocobalamin—CASP9—Innate Immune System—NRAS—uterine cancer	7.39e-05	0.000215	CbGpPWpGaD
Hydroxocobalamin—MUT—Disease—KRAS—uterine cancer	7.36e-05	0.000214	CbGpPWpGaD
Hydroxocobalamin—TCN2—Disease—HRAS—uterine cancer	7.35e-05	0.000214	CbGpPWpGaD
Hydroxocobalamin—MTRR—Disease—PTEN—uterine cancer	7.26e-05	0.000212	CbGpPWpGaD
Hydroxocobalamin—MMAB—Metabolism—PIK3CA—uterine cancer	7.16e-05	0.000209	CbGpPWpGaD
Hydroxocobalamin—TCN1—Metabolism—PIK3CA—uterine cancer	7.16e-05	0.000209	CbGpPWpGaD
Hydroxocobalamin—CASP9—Adaptive Immune System—NRAS—uterine cancer	7.1e-05	0.000207	CbGpPWpGaD
Hydroxocobalamin—AMN—Disease—PIK3CA—uterine cancer	7.08e-05	0.000206	CbGpPWpGaD
Hydroxocobalamin—MMAA—Disease—PIK3CA—uterine cancer	7.08e-05	0.000206	CbGpPWpGaD
Hydroxocobalamin—CUBN—Metabolism—EP300—uterine cancer	7.06e-05	0.000206	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—SOCS3—uterine cancer	6.99e-05	0.000204	CbGpPWpGaD
Hydroxocobalamin—MMAB—Disease—AKT1—uterine cancer	6.98e-05	0.000203	CbGpPWpGaD
Hydroxocobalamin—TCN1—Disease—AKT1—uterine cancer	6.98e-05	0.000203	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—ERBB2—uterine cancer	6.94e-05	0.000202	CbGpPWpGaD
Hydroxocobalamin—MTRR—Disease—EP300—uterine cancer	6.92e-05	0.000202	CbGpPWpGaD
Hydroxocobalamin—CUBN—Disease—KRAS—uterine cancer	6.79e-05	0.000198	CbGpPWpGaD
Hydroxocobalamin—MUT—Disease—PIK3CA—uterine cancer	6.76e-05	0.000197	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—CDH1—uterine cancer	6.71e-05	0.000195	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—CDKN2B—uterine cancer	6.69e-05	0.000195	CbGpPWpGaD
Hydroxocobalamin—TCN2—Metabolism—PIK3CA—uterine cancer	6.66e-05	0.000194	CbGpPWpGaD
Hydroxocobalamin—AMN—Disease—HRAS—uterine cancer	6.55e-05	0.000191	CbGpPWpGaD
Hydroxocobalamin—MMAA—Disease—HRAS—uterine cancer	6.55e-05	0.000191	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—IGF1R—uterine cancer	6.5e-05	0.000189	CbGpPWpGaD
Hydroxocobalamin—TCN2—Disease—AKT1—uterine cancer	6.49e-05	0.000189	CbGpPWpGaD
Hydroxocobalamin—MTRR—Disease—NRAS—uterine cancer	6.48e-05	0.000189	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—CDKN1B—uterine cancer	6.43e-05	0.000187	CbGpPWpGaD
Hydroxocobalamin—MMACHC—Metabolism—AKT1—uterine cancer	6.4e-05	0.000186	CbGpPWpGaD
Hydroxocobalamin—CASP9—Innate Immune System—KRAS—uterine cancer	6.36e-05	0.000185	CbGpPWpGaD
Hydroxocobalamin—MUT—Disease—HRAS—uterine cancer	6.25e-05	0.000182	CbGpPWpGaD
Hydroxocobalamin—CUBN—Disease—PIK3CA—uterine cancer	6.24e-05	0.000182	CbGpPWpGaD
Hydroxocobalamin—CASP9—Adaptive Immune System—KRAS—uterine cancer	6.11e-05	0.000178	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—SMAD3—uterine cancer	6.11e-05	0.000178	CbGpPWpGaD
Hydroxocobalamin—MTRR—Metabolism—PTEN—uterine cancer	6.08e-05	0.000177	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—CTNNB1—uterine cancer	6.07e-05	0.000177	CbGpPWpGaD
Hydroxocobalamin—AMN—Metabolism—PIK3CA—uterine cancer	5.93e-05	0.000173	CbGpPWpGaD
Hydroxocobalamin—MMAA—Metabolism—PIK3CA—uterine cancer	5.93e-05	0.000173	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—PTEN—uterine cancer	5.92e-05	0.000172	CbGpPWpGaD
Hydroxocobalamin—MMAB—Metabolism—AKT1—uterine cancer	5.85e-05	0.00017	CbGpPWpGaD
Hydroxocobalamin—TCN1—Metabolism—AKT1—uterine cancer	5.85e-05	0.00017	CbGpPWpGaD
Hydroxocobalamin—CASP9—Innate Immune System—PIK3CA—uterine cancer	5.85e-05	0.00017	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—FGFR2—uterine cancer	5.83e-05	0.00017	CbGpPWpGaD
Hydroxocobalamin—MTRR—Metabolism—EP300—uterine cancer	5.8e-05	0.000169	CbGpPWpGaD
Hydroxocobalamin—AMN—Disease—AKT1—uterine cancer	5.79e-05	0.000169	CbGpPWpGaD
Hydroxocobalamin—MMAA—Disease—AKT1—uterine cancer	5.79e-05	0.000169	CbGpPWpGaD
Hydroxocobalamin—CUBN—Disease—HRAS—uterine cancer	5.77e-05	0.000168	CbGpPWpGaD
Hydroxocobalamin—MUT—Metabolism—PIK3CA—uterine cancer	5.66e-05	0.000165	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—ERBB2—uterine cancer	5.66e-05	0.000165	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—EP300—uterine cancer	5.64e-05	0.000164	CbGpPWpGaD
Hydroxocobalamin—CASP9—Adaptive Immune System—PIK3CA—uterine cancer	5.61e-05	0.000164	CbGpPWpGaD
Hydroxocobalamin—MTRR—Disease—KRAS—uterine cancer	5.57e-05	0.000162	CbGpPWpGaD
Hydroxocobalamin—MUT—Disease—AKT1—uterine cancer	5.52e-05	0.000161	CbGpPWpGaD
Hydroxocobalamin—TCN2—Metabolism—AKT1—uterine cancer	5.44e-05	0.000158	CbGpPWpGaD
Hydroxocobalamin—CASP9—Innate Immune System—HRAS—uterine cancer	5.41e-05	0.000158	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—NRAS—uterine cancer	5.28e-05	0.000154	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—CDKN1B—uterine cancer	5.24e-05	0.000153	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—ERBB2—uterine cancer	5.23e-05	0.000152	CbGpPWpGaD
Hydroxocobalamin—CUBN—Metabolism—PIK3CA—uterine cancer	5.22e-05	0.000152	CbGpPWpGaD
Hydroxocobalamin—CASP9—Adaptive Immune System—HRAS—uterine cancer	5.19e-05	0.000151	CbGpPWpGaD
Hydroxocobalamin—MTRR—Disease—PIK3CA—uterine cancer	5.12e-05	0.000149	CbGpPWpGaD
Hydroxocobalamin—CUBN—Disease—AKT1—uterine cancer	5.1e-05	0.000148	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—ESR1—uterine cancer	4.99e-05	0.000145	CbGpPWpGaD
Hydroxocobalamin—MTR—Metabolism—PTEN—uterine cancer	4.96e-05	0.000144	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—CTNNB1—uterine cancer	4.95e-05	0.000144	CbGpPWpGaD
Hydroxocobalamin—AMN—Metabolism—AKT1—uterine cancer	4.85e-05	0.000141	CbGpPWpGaD
Hydroxocobalamin—MMAA—Metabolism—AKT1—uterine cancer	4.85e-05	0.000141	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—CDKN1B—uterine cancer	4.84e-05	0.000141	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—PTEN—uterine cancer	4.83e-05	0.000141	CbGpPWpGaD
Hydroxocobalamin—CASP9—Innate Immune System—AKT1—uterine cancer	4.78e-05	0.000139	CbGpPWpGaD
Hydroxocobalamin—MTRR—Disease—HRAS—uterine cancer	4.74e-05	0.000138	CbGpPWpGaD
Hydroxocobalamin—MTR—Metabolism—EP300—uterine cancer	4.73e-05	0.000138	CbGpPWpGaD
Hydroxocobalamin—MUT—Metabolism—AKT1—uterine cancer	4.62e-05	0.000135	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—EP300—uterine cancer	4.6e-05	0.000134	CbGpPWpGaD
Hydroxocobalamin—CASP9—Adaptive Immune System—AKT1—uterine cancer	4.59e-05	0.000134	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—CTNNB1—uterine cancer	4.57e-05	0.000133	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—KRAS—uterine cancer	4.54e-05	0.000132	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—PTEN—uterine cancer	4.46e-05	0.00013	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—CCL2—uterine cancer	4.39e-05	0.000128	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—NRAS—uterine cancer	4.31e-05	0.000125	CbGpPWpGaD
Hydroxocobalamin—MTRR—Metabolism—PIK3CA—uterine cancer	4.29e-05	0.000125	CbGpPWpGaD
Hydroxocobalamin—CUBN—Metabolism—AKT1—uterine cancer	4.27e-05	0.000124	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—EP300—uterine cancer	4.25e-05	0.000124	CbGpPWpGaD
Hydroxocobalamin—MTRR—Disease—AKT1—uterine cancer	4.18e-05	0.000122	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—PIK3CA—uterine cancer	4.18e-05	0.000122	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—NRAS—uterine cancer	3.98e-05	0.000116	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—HRAS—uterine cancer	3.86e-05	0.000113	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—KRAS—uterine cancer	3.71e-05	0.000108	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—ERBB2—uterine cancer	3.66e-05	0.000107	CbGpPWpGaD
Hydroxocobalamin—MTRR—Metabolism—AKT1—uterine cancer	3.5e-05	0.000102	CbGpPWpGaD
Hydroxocobalamin—MTR—Metabolism—PIK3CA—uterine cancer	3.5e-05	0.000102	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—CXCL8—uterine cancer	3.47e-05	0.000101	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—KRAS—uterine cancer	3.42e-05	9.97e-05	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—AKT1—uterine cancer	3.41e-05	9.94e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—PIK3CA—uterine cancer	3.4e-05	9.92e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—CDKN1B—uterine cancer	3.39e-05	9.87e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—CTNNB1—uterine cancer	3.2e-05	9.33e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—HRAS—uterine cancer	3.15e-05	9.18e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—PIK3CA—uterine cancer	3.14e-05	9.16e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—PTEN—uterine cancer	3.12e-05	9.09e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—EP300—uterine cancer	2.98e-05	8.67e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—HRAS—uterine cancer	2.91e-05	8.47e-05	CbGpPWpGaD
Hydroxocobalamin—MTR—Metabolism—AKT1—uterine cancer	2.86e-05	8.32e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—VEGFA—uterine cancer	2.82e-05	8.21e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—NRAS—uterine cancer	2.78e-05	8.11e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—AKT1—uterine cancer	2.78e-05	8.1e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—AKT1—uterine cancer	2.57e-05	7.48e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—KRAS—uterine cancer	2.4e-05	6.98e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—PIK3CA—uterine cancer	2.2e-05	6.41e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—TP53—uterine cancer	2.13e-05	6.2e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—HRAS—uterine cancer	2.04e-05	5.93e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—AKT1—uterine cancer	1.8e-05	5.24e-05	CbGpPWpGaD
